Juniper, scientifically known as Juniperus communis, is a plant with numerous therapeutic properties, valued in both traditional and folk medicine. Its berries are used to relieve digestive disorders, thanks to their carminative and stomachic qualities, as well as for their diuretic and anti-inflammatory properties, mainly due to the presence of terpinene-4-ol in the essential oil.

Despite its benefits, the therapeutic use of juniper has always had limitations, such as the difficulty of masking the strong taste of the berries and the need for controlled release of active ingredients.

IPS, however, offers an innovative solution: microcapsules containing juniper oil. These microcapsules are obtained through a coacervation process that preserves the integrity of the essential oil while allowing for a more diversified formulation. The size of the microcapsules ranges from 100 to 600 µm, with an oil content of up to 85%, ensuring a high concentration of active ingredients.

The microencapsulation process offers numerous advantages over traditional methods: it transforms liquids into easily manageable powders, masks unpleasant tastes and odors, and significantly improves the stability of the final product. Furthermore, the technology used by IPS ensures a controlled and prolonged release of active ingredients in the gastrointestinal tract, increasing the effectiveness of the treatment.

IPS stands out as a leading supplier of microencapsulated raw materials. The use of juniper microcapsules for supplement production ensures not only therapeutic efficacy but also an enhanced consumer experience. With a constant commitment to research and the development of cutting-edge solutions, IPS is the ideal partner for those looking to overcome the limitations of traditional formulations and offer high-quality, scientifically validated products.